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Congenital anomalies and its causes, particularly, by external factors are the aim of
the field called teratology. The external factors studied by teratology are known as
teratogens and can be biological or environmental factors for example, chemicals,
medications, recreational drugs, environmental pollutants, physical agents (e.g.,
X-rays and maternal hyperthermia) and maternal metabolic conditions. Proving the
teratogenicity of a factor is a difficult task requiring epidemiology studies as well as
experimental teratology evidence from the use of animal models, one of which is the
chicken embryo. This model in particular has the advantage of being able to follow
development live and in vivo, with rapid development hatching around 21 days, is cheap
and easy to manipulate and to observe development. All this allows the chicken embryo
to be used in drug screening studies, teratogenic evaluation and studies of mechanisms
of teratogenicity. The chicken embryo shares morphological, biochemical and genetic
similarities with humans as well as mammalian species, making them ideal to ascertain
the actions of teratogens, as well as screen drugs to test for their safety. Pre-clinical trials
for new drugs are carried out in rodents and rabbits, however, chicken embryos have
been used to screen new compounds or analogs of thalidomide as well as to investigate
how some drugs can lead to congenital malformations. Indeed, the chicken embryo has
proved valuable in understanding how many congenital anomalies, seen in humans,
arise following teratogen exposure. The aim of this review is to highlight the role of the
chicken embryo as an experimental model for studies in teratology, exploring its use in
drug screening studies, phenotypic evaluation and studies of teratogenic mechanisms
of action. Here, we discuss many known teratogens, that have been evaluated using
the chicken embryo model including some medicines, such as, thalidomide, valproic
acid; recreational drugs including alcohol; environmental influences, such as viruses,
specifically ZIKV, which is a newly discovered human teratogen. In addition, we discuss
how the chicken embryo has provided insight on the mechanisms of teratogenesis of
many compounds and also how this impact on drug safety.
Keywords: congenital malformations, preclinical trials, gene expression, teratogens, embryonic anomalies,
drug/medicine safety, ZIKV, thalidomide
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INTRODUCTION
In humans, data regarding congenital anomalies (CA) induced
by teratogens are from observational studies, in which case
reports and epidemiological studies indicate an increase of the
rate of some malformation and potential risk factors. Due
to the fact that CA can cause infant and childhood death,
illness and disabilities, it is important to have such methods
to allow further investigation of their causes, risk factors and
mechanisms [World Health Organization (WHO), 2020a]. Such
investigations help directly in the development of strategies
to prevent further occurrence, therapeutic interventions and
deaths from CAs.
Nowadays many tools and approaches are utilized to study
the causes and mechanisms that underlie a CA, from a range of
cell culture assays to multiple animal and embryo models. In the
context of CA, the chicken embryo model is very relevant since
a lot of what is known about embryo development comes from
studies with this model (Davey et al., 2018). In addition, many
characteristics of the chicken embryo make it very attractive.
For example, the chicken embryo offers the advantage of being
able to study development live and in vivo throughout gestation
(Davey et al., 2018). The chicken embryo also has the advantage of
allowing easy administration of chemicals, compounds, external
agents that may or are alleged to cause CA to determine their
actions upon the embryo. This then allows the study of such
CA and enables multiple analyses, genetic and morphological, to
be performed in order to understand how the CA was caused
and shed light on therapeutic strategies as well as how they
could be prevented.
This review aims to highlight the role of the chicken
embryo as an experimental model for studies in teratology.
For that, we first, review congenital anomalies, teratogenesis,
experimental teratogenesis and the advantages of the chicken
embryo for such research. Secondly, we discuss examples of
how and why the chicken embryo is used for evaluation
of risks of exposure to different teratogens, understanding




Congenital Anomalies are structural, metabolic or functional
abnormalities existent on birth and can be diagnosed prenatally,
at birth or even later [Christianson et al., 2006; World Health
Organization (WHO), 2020a]. CAs represent around 25%
of infant deaths in the United States of America and 15–
39% in Latin America [World Health Organization (WHO),
2020b]. Worldwide, out of 2.5 million deaths of children
under 28 days of age in 2017, 283,582 were due to CA
[World Health Organization (WHO), 2020b]. Most incidences
of CA are from unknown causes, representing 50–75% of
all cases [Brent, 2001; World Health Organization (WHO),
2020a]. The known causes are divided into chromosomal and
genetic factors, environmental factors, such as exposure to a
teratogen or lack of some nutrient in the diet, or a combination
between them (Moore et al., 2019). Environmental factors
are responsible for around 10% of the anomalies observed
(Brent, 2001).
There have been many different approaches in understanding
the effects of environmental exposure to the embryo over the past
century. An important landmark in teratogenesis (particularly
in experimental teratogenesis) was Hale’s publication in 1935.
In Hale’s studies, it was reported that pregnant pigs fed
with a diet deficient in vitamin A resulted in newborns
with congenital malformations (Hale, 1935). These findings
were next confirmed in rats by Josef Warkany in 1946,
which work underpins the Principles of Teratology postulated
first by Wilson (Warkany and Schrafenberger, 1946; Wilson,
1973). From this study, further work in animal models and
observations in humans indicated that environmental factors,
including maternal conditions, can have important effects upon
the development of the embryo and adult disease (Barker
and Osmond, 1986; Calkins and Devaskar, 2011). Up until
the 1940s, it was thought the placenta worked as a barrier
between the embryo/fetus and the outside world, protecting
it from environmental agents such as drugs and pathogens.
Nevertheless, reports from children whose mothers have had
Rubella during pregnancy being born with cataract showed that
environmental factors can cross the placenta and damage the
embryo (Gregg, 1941).
Environmental factors with the potential of causing CAs
in embryos and fetuses exposed during their development are
named teratogens. The science that studies the CAs caused by
these teratogens and how they affect the embryo by studying
pathways and mechanisms that could be caused or altered by
them is known as teratology (“teratos” = monster, “logos” = study;
Ujházy et al., 2012). A teratogen can be any factor that is
extrinsic to embryonic development, such as recreational drugs,
medications, biological agents, x-rays and maternal conditions
(Brent, 2001; Fraga et al., 2016; Vargesson and Fraga, 2017;
Moore et al., 2019). Alcohol, cocaine and nicotine are examples of
recreational drugs that are teratogenic (Cambell, 2003; Williams
et al., 2015; Holbrook, 2016). Along with recreational drugs,
chemicals like mercury, lead and cadmium; medicines like
valproic acid, retinoic acid, phenytoin, thalidomide (Gilbert-
Barness, 2010; Vargesson and Fraga, 2017); physical agents such
as radiation; and maternal conditions such as obesity, pre-
eclampsia and hyperthermia, can also be teratogenic (Ferm and
Carpenter, 1967; Pleet et al., 1981; Léonard et al., 1983; Bellinger,
1994; Fattibene et al., 1999; Baeten et al., 2001; Gilbert-Barness,
2010; Vargesson and Fraga, 2017).
Perhaps the most famous (or infamous) teratogen is
thalidomide and an example of a more recently discovered
teratogen is Zika virus (ZIKV). Thalidomide cause a group of
malformations in the limbs, heart, eye, ear, and internal organs
(Vargesson, 2015), and led to changes in the way medicines
are tested and evaluated (Vargesson, 2013). Thalidomide was
originally used as a sedative and found to also be effective
in treating morning sickness. Thalidomide was thought to be
safe. Tragically, more than 10,000 children were born in the
late 1950’s and early 1960’s with rare and severe malformations
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caused by the use of thalidomide during pregnancy (Kim
and Scialli, 2011; Vargesson, 2019). More recently, ZIKV is a
biological agent, and teratogen, that caused Congenital Zika
Syndrome in babies born to mothers who were infected with
ZIKV during pregnancy (Rasmussen et al., 2016; Schuler-Faccini
et al., 2016). Patients with Congenital Zika Syndrome exhibit
microcephaly and other CAs (de Araújo et al., 2016; Marrs
et al., 2016; Schuler-Faccini et al., 2016; Del Campo et al., 2017).
Children born in areas with no ZIKV have no increased levels
of microcephaly.
EXPERIMENTAL TERATOGENESIS
The classification of an environmental factor as a teratogen
is not an easy task. Wilson proposed six principles of
teratology to provide a guide to determining and understanding
teratogenic agents (Wilson, 1973). These include susceptibility
to teratogenesis depends on the genotype, depends on the
developmental stage of the embryo, how the teratogen
act, the nature of the teratogen and how its absorbed its
maternal/placental transfer, proposed different classifications of
teratogenic insult (death, malformation, growth retardation, and
functional defect) (Wilson, 1973). These principles underpin the
field of teratology today. More recently, Shepard (1994) further
elaborated the Wilson Principles and proposing additional
criteria to guide the process of proving the teratogenicity
of a factor in humans, including guidance on clinical and
epidemiological findings to indicate if the occurrence of a
CA in a population or a cluster of individuals is linked to an
environmental influence or exposure.
The history of human teratogenesis shows that it is usually
an astute clinician who observes and identifies a potentially
teratogenic situation. The demonstration of biological plausibility
of the teratogenic potential of a determined exposure is
usually determined by in vivo studies, performed through
experimental teratology using animal models. In addition, the
study of teratogenesis using experimental models is essential to
understand how a specific teratogenic agent affects embryonic
development in vivo, to help understand the agent and find
treatments or prevention of congenital anomalies. Experimental
teratogenesis is fundamental to evaluate and understand the
mechanisms that lead to the malformations caused by exposure to
the agent. Experimental models are also important and useful for
drug development when animals are used in preclinical studies to
evaluate reproductive and developmental toxicity and evaluation
of exposure risk to a specific agent. Studies in animals also allow
control of the dose and period of exposure, variables that can
apply directly to a teratogenic effect (for example, Mahony et al.,
2013; Beedie et al., 2016a, 2017; Cugola et al., 2016; Vargesson and
Fraga, 2017).
A wide range of animal models has been used in studies
of experimental teratogenesis. The most commonly utilized
experimental models are embryos of mice, rats, zebrafish,
chicken, rabbit, and non-human primates (for example, Janer
et al., 2008; Therapontos et al., 2009; Ema et al., 2010; Ito et al.,
2010; Cassina et al., 2012; Mahony et al., 2013; Beedie et al.,
2015, 2016a,b; Davey et al., 2018). The choice of the appropriate
experimental model depends not only on representing the
phenotypes observed in humans but also considers the length of
development and the accessibility of the organs and structures
potentially affected. Using multiple animal models helps confirm
how an alleged teratogen acts and the damage it can cause.
Many other factors help in the decision of the most suitable
animal model to be used such as facility of manipulation, access
to embryo for observation, ethical and founding limitations,
species-specificity criteria and susceptibility to the teratogen
(Cassina et al., 2012).
Due to the tragedy of thalidomide, for reproductive and
developmental toxicity evaluation in preclinical studies, it is now
mandatory to use multiple different animal species (Vargesson,
2013). This is important because the sensitivity to some
teratogenic agents varies between different species (Janer et al.,
2008; Vargesson, 2015). For example, rodents are not very
sensitive to thalidomide (Janer et al., 2008; Vargesson, 2015).
Interestingly, rodents are also not naturally susceptible to ZIKV
infection (Grant et al., 2016), but can be induced to be susceptible
(Cairns et al., 2018). The chicken embryo on the other hand is
susceptible to thalidomide and also to ZIKV, making it a key
model for such studies (Vargesson, 2015; Goodfellow et al., 2016;
Willard et al., 2017; Thawani et al., 2018, 2020; Wachholz et al.,
2021).
The establishment of experimental models using different
teratogens is fundamental since they are essential for the process
of understanding the pathways involved and the mechanisms of
teratogenesis of each teratogen. Taking into account biological
teratogens, such as ZIKV, the experimental models remain
indispensable during the process of development of a drug
that can treat or prevent any damage caused by exposure
during pregnancy.
THE CHICKEN EMBRYO
The chicken embryo (Gallus gallus; Figure 1) has been used for
more than two millennia as an experimental model for studies
in a wide range of fields including naturalism, art, philosophy
and the beginning of biological sciences trying to answer the
most fundamental questions of life, for example how an embryo
form (Stern, 2004). For instance, chicken embryo development
was first studied in the Egyptian era around 300 BC, and by the
Greek scientist, Aristoteles who performed studies focused on
anatomy and embryo morphology. Even Leonardo da Vinci used
chicken embryos to explore anatomy and embryo development
(Stern, 2004). During the last 50 years, in particular, studies
with chicken embryos have being contributing to the knowledge
about some of the most important concepts in developmental
biology particularly in limb development and nervous system
development and more recently drug safety (Vargesson et al.,
1997; Lewandoski et al., 2000; Stern, 2004; Davey and Tickle,
2007; Towers and Tickle, 2009; Vergara and Canto-Soler, 2012;
Mahony and Vargesson, 2013; Beedie et al., 2016a,b; Davey et al.,
2018). Indeed, the chicken embryo was fundamental to the work
of the neurobiologist Rita Levi-Montalcini who won a Nobel
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FIGURE 1 | Key developmental structures of the chicken embryo and their timings. (A) The chicken embryo develops rapidly, the developing heart, limbs, eyes and
brain can be used to evaluate teratogenic potential of teratogens such as thalidomide and Zika virus. By HH Stage 11 (Embryonic day E1.5-2), brain vesicles are
developing and exposure to potential teratogens that might affect brain development may confirm their harmfulness, which become more evident by HH Stages 27 -
30. By HH Stage 18 (E3), limb buds can be observed and used to test substances with potential to affect limb development, which can be observed throughout
development and confirmed by HH Stage 35 (E9-9.5), when cartilage elements can be better visualized. (B) Examples of teratogenic exposure and their effects on
the development of chicken embryo; ZIKV induces to brain defects (white arrows; described previously in Wachholz et al., 2021) and CPS49, an antiangiogenic
analog of thalidomide, which causes limb defects with reduction or absence of cartilage elements (black arrows; described previously in Therapontos et al., 2009).
Images in B are from archives from Lucas Fraga’s Lab (ZIKV) and Neil Vargesson’s Lab (CPS49). BV, Brain Vesicles; NT, Neural Tube; FL, Forelimb; HL, Hindlimb; Te,
telencephalon; Me, Mesencephalon; Ht, Heart; OV, Otic Vesicle.
Prize in 1986. The chicken embryo was also one of the first
model organisms to study the actions of the most infamous
teratogen, thalidomide (Jurand, 1966; Vargesson, 2009; Davey
et al., 2018).
The importance, influence and wide use of the chicken
embryo is due to the fact that they are easy to manipulate
and to maintain, they are a large embryo and thus, easy to
visualize live and in ovo and follow development throughout
gestation. They are also low cost and can be obtained in large
numbers. By using chicken embryos, it is possible to analyze
the development macroscopically and without embryonic and/or
maternal sacrifice, which makes the analyses easier and faster
when compared to other models that need long processing
procedures. The embryo is isolated from its mother in an egg,
and develops rapidly and is fully formed by day 10 and hatches
around day 21. Together this makes the chicken embryo a
very favorable model organism and supports the “3Rs”—the
replacement, refinement and reduction of animals in research,
as there is no need to euthanize the mother to obtain embryos,
unlike mammalian species (Beedie et al., 2017; Vargesson and
Fraga, 2017; Davey et al., 2018).
It is important to highlight that there are differences between
chicken and mammalian embryo development. Chicken embryo
development is external to the body in a self-contained egg
with a yolk sac, which contains nutrients and molecules with
a maternal origin. Unlike mammals, including humans, where
the embryo develops inside the body, with a placenta supplying
nutrients, and as there is also a maternal liver, means drugs can
also be metabolized before arriving at the embryo. The chicken
embryo not having a maternal metabolism allows scientists to
understand the effect of some compounds in the embryo with the
absence of maternal influence as well as help determine if a drug’s
action requires maternal metabolism. Phenytoin, for instance, is
an anti-epileptic drug that exerts its teratogenic effects through
its arenes oxides metabolites (Spielberg et al., 1981; Strickler
et al., 1985). Chicken embryos present with neural tube defects
when they are exposed to phenytoin (Temiz et al., 2009). This
suggests that the effect of phenytoin is not related exclusively
to maternal metabolism and, therefore, reinforces the usefulness
of the chicken embryo model. In addition, because of species-
specificity of teratogenesis, some agents are not teratogenic in
rodents, such as thalidomide (Vargesson, 2019). This is why
chickens (and other species) can and have helped work out
the actions of these drugs and confirm their safety (Vargesson,
2015). Therefore, as a method of understanding how a drug acts
and determining its potential to cause teratogenesis, the chicken
embryo remains powerful.
Chicken embryo developmental stages were extensively
described by Hamburger and Hamilton (1951), and which are
used today when studying chicken embryo development. Their
description and delineation of a system of stages also help
to compare chicken embryo development with other animal
species and also human development, allowing research in
human congenital anomalies to be performed in this model.
For example, following the first 3 days of development when
gastrulation and neurulation occurs, heart development quickly
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follows (Hamburger and Hamilton, 1951). Followed rapidly
from 3 days, by the limb buds, together with the formation
of other organs like eyes, ear and brain (Hamburger and
Hamilton, 1951; Davey et al., 2018; Vilches-Moure, 2019;
Figure 1). Together with the comparable embryology and
physiology, there is a high genome conservation between
mammals and chicken. Furthermore, the chicken genome is
sequenced (Wallis et al., 2004).
One of the limitations of the use of chicken embryos is
its relative lack of genetic tractability, compared to rodents.
This is due to fertilization and early developmental events
occurring inside the hen, followed by the egg shell being
produced before being laid. This makes techniques like
targeted gene knockouts through homologous recombination
very difficult. However, it is possible to misexpress genes using
the RCAS virus system (Logan and Tabin, 1998) and inhibit
genes using RNAi (Krull, 2004). Also, more recently genomic
editing techniques using CRISPR/Cas9 have started to be used
chicken embryos, allowing targeted gene knockdowns (Williams
et al., 2018; Chojnacka-Puchta and Sawicka, 2020). Taken
all together, these techniques reinforce the usefulness of the
chicken embryo in development, how drugs affect development
and also genomic and molecular analyses (Burt et al., 1999;
Stern, 2018).
THE CHICKEN EMBRYO IN THE
EVALUATION AND UNDERSTANDING OF
TERATOGENS AND DRUG SAFETY
The development of a new drug requires different steps and
an important one is the prediction of the potential teratogenic
effects during development (Beedie et al., 2017). In preclinical
trials, drugs in development are tested in pregnant animals,
more frequently in mammals, which have a more similar
physiology to humans. Since the thalidomide tragedy and the
discovery of the species-specificity property of teratogenesis,
it is necessary to perform drug screening in more than
one species, including a rodent and a non-rodent, to attest
its safety during development (Vargesson, 2013). Presently,
testing of new drugs is mainly carried out in rodents and
rabbits. However, chicken embryos have proved useful to
understand actions of drugs linked to causing developmental
problems and understanding a suspected teratogens mechanism
of action, for example, thalidomide (Jurand, 1966; Knobloch
et al., 2007; Therapontos et al., 2009; Vargesson, 2015;
Beedie et al., 2016a,b). In addition, the advantage of live
and in vivo observations of the chicken embryo following
drug exposure, allows scientists to understand the drugs
actions when applied at different timepoints and concentrations
and drug actions can be followed throughout development.
Chicken embryos are also being used as a preclinical screen
to ascertain potential actions/side-effects of new drugs as
well as screen drugs, for example thalidomide, phenytoin,
ethanol, to understand their actions (Beedie et al., 2015,
2016a,b; Davey et al., 2018). This can (i) help reduce the
number of rodents required in preliminary drug screening, as
studies in the chicken embryo may indicate harmful effects
and thus, not to be followed up in rodents; and (ii) give
some insight into potential mechanisms of action of the drug
as well as safety.
The chicken embryo enables analysis of the effects of a
drug throughout development (and live and in ovo) including
through early stages of organogenesis (Beedie et al., 2017),
which is difficult in models such as rodents. Effects of
drugs/compounds/agents can also be followed throughout
development. As studies of the phenotypic spectrum and
teratogenic risk of an agent in humans are limited to
epidemiological analyses, this can be carried out in the chicken
embryo as can a dose-response analysis and observation of the
effects of varying the timing of exposure upon development, to
determine the most sensitive time of development for each agent.
This further underlines the importance of the chicken embryo as
an excellent experimental model to follow and determine the risks
of a teratogen (Wachholz et al., 2021).
For example, the chicken embryo model can be used to mimic
human phenotypes after teratogen exposure, as it is the recent
case of Zika virus. Wachholz et al. (2021) was able to mimic
the microcephaly phenotype observed in humans after Zika
virus infection during development in chicken embryos using a
non-invasive method of infection. Chicken embryos have been
used as a model for ZIKV infections since 1951 (Taylor, 1952)
and today there are multiple research groups using the chicken
embryo as a model of Congenital Zika Syndrome (Goodfellow
et al., 2016; Willard et al., 2017; Thawani et al., 2018, 2020;
Wachholz et al., 2021).
Some of the drugs/medicines that have been studied in chicken
embryos to identify potential and/or understand teratogenic
actions include thalidomide and thalidomide analogs including
pomalidomide and tetrafluorinated thalidomide analogs with
anti-cancer properties (Kemper and Berger, 1962; Kemper, 1963;
Jurand, 1966; Tamilarasan et al., 2006; Knobloch et al., 2007;
Therapontos et al., 2009; Vargesson, 2009; Ito et al., 2010; Mahony
et al., 2013; Vargesson, 2019; Beedie et al., 2015, 2016a); the
new-generation anti-epileptic medication Levetiracetam (Tureci
et al., 2011); the anti-epileptic medicine sodium valproate
(Whitsel et al., 2002); as well as anti-angiogenic anti-cancer
compounds (Beedie et al., 2015, 2016a,b; Table 1). The chicken
Chorioallantoic Membrane (CAM) has been also used to screen
the anti-tumorigenic activity of overexpressed proteins (Valiulytë
et al., 2019) and plays an important role in other cancer and
cardiovascular studies, including bioengineering (Warnock et al.,
2013; Kain et al., 2014; Nowak-Sliwinska et al., 2014).
Other examples of teratogens studied in chickens include
studies looking at valproic acid exposure which can cause neural
tube defects in the chicken embryo, together with cardiovascular
anomalies (Whitsel et al., 2002; Hsieh et al., 2012, 2014). Limb and
skeletal anomalies are also observed after exposure of valproic
acid and retinoic acid (Tamarin et al., 1984; Whitsel et al., 2002).
Congenital anomalies of the heart and cardiovascular system
were also described after chicken embryo exposure to alcohol
and retinoic acid (Fang et al., 1987; Whitsel et al., 2002). The
exposure of thalidomide in chicken embryo has shown to cause
limb anomalies, resembling the ones observed in humans, such
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TABLE 1 | Morphological phenotypes observed after exposure of chicken embryos to teratogens.
Teratogen Phenotypes References
Alcohol Reduced body size; brain malformations; heart anomalies; ventricular septal defect;
otic vesicle anomalies; Defects in the caudal region; spina bifida
Sandor and Elias, 1968; Sandor, 1968; Fang
et al., 1987
Cadmium Limb, heart, vasculature, liver, neural tube, somites, and reproductive system
anomalies
Cullinane et al., 2009; Yamamoto et al., 2012
Retinoic acid Heart anomalies; cardia bifida; facial anomalies; limb anomalies. Tamarin et al., 1984; Osmond et al., 1991
Thalidomide and
thalidomide analogs
Limb and digit anomalies; amelia; microphthalmia; reduced body size;
hemorrhaging
Stephens, 2009; Therapontos et al., 2009; Ito
et al., 2010; Beedie et al., 2016a
Valproic acid Neural tube defects; Cardiovascular anomalies; Craniofacial defects; limb and
skeletal malformations
Whitsel et al., 2002; Hsieh et al., 2012, 2014
Zika virus Reduced brain size; reduced body size; mesencephalon, telencephalon and eye
reduction size; mesencephalon malformations; understaged embryos; inner ear
dysmorphogenesis
Goodfellow et al., 2016; Thawani et al., 2018,
2020; Willard et al., 2017; Wachholz et al., 2021
as amelia (Stephens, 2009; Ito et al., 2010; Beedie et al., 2016a),
phocomelia and radial dysplasia (Therapontos et al., 2009; Davey
et al., 2018).
The chicken embryo has also been used to study treatments to
prevent congenital anomalies caused by exposure of teratogens.
For example, (i) damage caused by valproic acid, can be prevented
or can be rescued by exposure with resveratrol, vitamin E, folic
acid, n-acetylcysteine and vitamin C (Hsieh et al., 2012, 2014);
(ii) damage caused by thalidomide has been prevented or rescued
through application of nitric oxide (Siamwala et al., 2012); (iii)
Cadmium induced damage can also be rescued by nitric oxide
exposure (Veeriah et al., 2015).
Furthermore, the chicken embryo has also been used
to study the consequences of teratogens in childhood and
adult life (i.e., late-onset effects). For example, studies
have used this model to analyze behavioral and memory
impairments after prenatal exposure of factors, including
ethanol, morphine, hypoxia, malnutrition, D-cycloserine,
and others (Dose et al., 1995; Steele et al., 1996; Rodricks
et al., 2004; Che et al., 2005; Rao and Chaudhuri, 2007;
Smith et al., 2011; Mohammad et al., 2012). It has been
observed that ethanol and morphine can affect long term
memory in chicken when treated prenatally (Che et al., 2005;
Rao and Chaudhuri, 2007). Along with memory, behavioral
effects are also observed (Dose et al., 1995; Smith et al.,
2011; Mohammad et al., 2012; Johnsson et al., 2016). Some
of the outcomes observed included increase of fearfulness
and tonic immobility and reduction of reflexive motor
activity. Interestingly, the chicken was already used as a
genomic model for tonic immobility and anxiety behavior
(Johnsson et al., 2016; Fogelholm et al., 2019). Whether such
late-onset effects are caused by brain malformations or if
they occur in an independent manner, this remains to be
further clarified. Nevertheless, chicken embryos are useful in
investigating these outcomes.
Although the chicken embryo is a good model for
understanding development and for understanding drug
action it is not a standard system for pre-clinical drug
screening. Consequently, most of the drugs studied in
the chicken embryo the pharmacokinetic information is
unclear. However, while the chicken embryo is not a standard
tool for pharmacokinetics, it has been used in studies of
toxicogenomics related to environmental exposure of bisphenol
A alternatives, organic flame retardants and 6-OH-BDE47,
which is a Hydroxylated polybrominated diphenyl ether (Peng
et al., 2016; Pagé-Larivière et al., 2018; Sharin et al., 2021),
indicating this is an area of expansion in the chicken embryo
field, and which would further enhance its use in understanding
pharmacokinetics.
THE CHICKEN EMBRYO AND
UNDERSTANDING MECHANISMS OF
TERATOGENESIS
While many teratogens have been identified that are known
to cause birth defects, how they cause the birth defects has
remained unclear. Given the advantages of the chicken embryo,
many teratogenic agents mechanistic bases have begun to
be identified and include thalidomide, valproic acid, alcohol,
cocaine, nicotine, retinoic acid and cadmium just to mention a
few (Wiens et al., 1992; Venturini and Sparber, 2001; Cullinane
et al., 2009; Therapontos et al., 2009; Ito et al., 2010; Hsieh
et al., 2012; Yamamoto et al., 2012; El-Beltagy et al., 2015).
Understanding the mechanisms of teratogenicity of a factor
can shed light on the biological action of the compound as
well as how it causes congenital anomalies, which can lead to
potential ways of making safer drugs. In addition, the more
we understand how congenital anomalies occur strategies of
prevention can be determined.
Using chicken embryos, it was shown that one of the effects
of alcohol on embryo development is due to the activation of
a G-protein and a calcium-dependent mechanism of apoptosis
(Table 2). This process was observed to cause effects in the
brain and neural tube (Garic-Stankovic et al., 2005; Flentke
et al., 2014). Chicken embryo exposure with alcohol was further
used to understand the malformations observed in Fetal Alcohol
Syndrome (FAS), for example, the craniofacial anomalies (Smith,
2008). Therefore, the chicken embryo is a good model to
understand how organs and tissues are affected and which
molecular pathways are disrupted (Garic-Stankovic et al., 2005;
Smith, 2008; Flentke et al., 2014).
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The chicken embryo is also known as one of the models
that has helped to understand how thalidomide caused such
severe damage to the human embryo. While the precise
mechanisms remain to be fully determined, of the many proposed
mechanisms, there are three which are considered more likely to
be the cause of thalidomide’s teratogenicity (D’Amato et al., 1994;
Knobloch et al., 2007, 2017; Therapontos et al., 2009; Ito et al.,
2010; Vargesson, 2013, 2015, 2019; Vargesson and Hootnick,
2017). They include anti-angiogenesis, oxidative stress induction
and the binding of thalidomide to a protein named Cereblon.
The chicken embryo demonstrated the antiangiogenic potential
of thalidomide as a cause for limb deformities (Therapontos
et al., 2009; Vargesson, 2009; Davey et al., 2018). Furthermore,
the oxidative stress and cell death induction mechanism was
tested in chicken embryos, where following thalidomide exposure
upregulation of bone morphogenetic protein (bmp) and Dickkopf
WNT Signaling Pathway Inhibitor 1 (dkk1) genes, involved in
cell death was observed (Knobloch et al., 2007). Other studies
in chicken embryos have also observed the downregulation of
fgf10 and fgf8 mRNA, and induction of apoptosis (Knobloch
et al., 2007; Therapontos et al., 2009; Ito et al., 2010).
More recently the binding of thalidomide to Cereblon protein
was first described using the chicken embryo as one of the
approaches (Ito et al., 2010). Cereblon is a ubiquitin ligase
whose function is to tag and remove unwanted molecules. The
binding of thalidomide with Cereblon results in a disruption
of cellular signaling. Precisely how the thalidomide/Cereblon
complex causes the actual tissue damage is unclear, and there
is also evidence that thalidomide may too be acting in a
cereblon-independent mechanism, particularly with respect to
thalidomide’s actions on the blood vessels (Beedie et al., 2020;
Peach et al., 2020).
The chicken embryo has also shed light on how Valproic
acid, used in humans to treat epilepsy, can cause embryonic
malformations. In chicken embryos exposed to Valproic acid,
damage to the embryo is rapidly observed (notably to limbs and
eyes) through inhibition of angiogenesis, induction of oxidative
stress and inhibition of histone deacetylase and key genes
involved in tissue development including Pax2 and Pax6 (Whitsel
et al., 2002; Chuang et al., 2012; Hsieh et al., 2012; Table 2).
Finally, although the molecular mechanisms of ZIKV
teratogenesis are still to be fully determined, some important
advances have been made using chicken embryos to
understand how exposure to ZIKV during development
causes malformations and the molecular basis of this. The
first experiments aiming to understand the teratogenesis of
ZIKV using as experimental models chicken embryos showed
microcephaly, reduction on the head size, indicating disrupted
brain growth, reassembling the CZS patients phenotype and
giving a clue of which molecular mechanism could be involved
(Thawani et al., 2018). Thawani et al. (2018) have demonstrated
that ZIKV impairs the expression of important signaling
molecules such as shh, bmp7, and fgf8 in specific regions of
the developing brain. Such findings are important to increase
knowledge about this recently discovered human teratogen,
however, further studies are necessary to better define the
mechanisms of teratogenesis of this virus.
CONCLUSION AND PERSPECTIVES
The chicken embryo model allows live and in ovo studies
and analyses throughout development to define and evaluate
potential risks of compounds, determine teratogenic phenotypes
and understand and describe the mechanism involved in its
teratogenic process. All this is essential to create and design
strategies, as well as preventive and therapeutic measures
in order to avoid the occurrence of congenital anomalies.
And equally important to help design safer drugs and
medicines in the future.
Thalidomide is a great example of the importance of the
chicken embryo, since it helped to understand the mechanisms
of teratogenesis and to the identification and screening of safer
alternative drugs (Jurand, 1966; Beedie et al., 2016a; Vargesson,
2019). ZIKV is also another good and recent example of
this experimental model, since the chicken embryo is helping
to understand the mechanisms of viral teratogenesis and to
aid design prevention strategies to avoid the occurrence of
malformations through the screening of new drugs aimed at
ameliorating the ZIKV actions on the embryo.
Finally, the knowledge obtained through chicken embryos
permits the discovery and testing of new drugs capable of
avoiding or to prevent phenotypes caused by exposure to
teratogenic agents during development.
TABLE 2 | Examples of mechanisms of teratogenesis of some teratogens using chicken embryos as experimental models.
Teratogen Mechanism References
Alcohol Activation of G-protein; Apoptosis induction; CaMKII activation; Dysregulation of
beta-catenin signaling; Reduction in neural cells proliferation.
Garic-Stankovic et al., 2005; Giles
et al., 2008; Flentke et al., 2014
Thalidomide Antiangiogenesis; Induction of oxidative stress; Thalidomide binding to
Cereblon; Upregulation of bmp and dkk1; Downregulation of fgf10 and fgf8;
Induction of apoptosis.
Knobloch et al., 2007; Therapontos
et al., 2009; Ito et al., 2010
Valproic acid Inhibition of angiogenesis; Induction of oxidative stress; Inhibition of hdac;
Reduction of pax-2 and pax-6 levels; Downregulation of sod and rbp4.
Whitsel et al., 2002; Chuang et al.,
2012; Hsieh et al., 2012, 2013
ZIKV Reduced transcript level of shh, bmp7 and fgf8; Patched1 reduction. Thawani et al., 2018
CaMKII, Ca2+/calmodulin-dependent protein kinase II; bmp, bone morphogenetic protein; dkk1, Dickkopf WNT Signaling Pathway Inhibitor 1; fgf10, fibroblast growth
factor 10; fgf8, fibroblast growth factor 8; hdac, histone deacetylase; sod, superoxide dismutase; rpb4, retinol binding protein 4; fgf8, fibroblast growth factor 8; bmp7,
bone morphogenetic protein 7; shh, sonic hedgehog.
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